Objective
The client is one of the top global manufacturers of pharma products, focused on creating breakthrough treatments for respiratory disease, wanted to have comprehensive understanding of the COPD disease area landscape and changing market dynamics with respect to the current & future market events, with focus on main aspects as below,
– Incidence, prevalence, diagnosed & treatment eligible patient pool
– Patient share by disease characteristics
– Current clinical practices and future treatment paradigm
– Product attribute and unmet need analysis
– Emerging therapies and market potential
Approach
eQuantX analysts performed extensive secondary research by referring to a diverse range of sources, including news platforms, research publications, regulatory bodies, clinical trial registries, and various other reputable outlets. Under primary market research, eQuantX conducted PMR through a systematic panel administration process which includes continuous lead generation, shortlisting of leads through desk research and industry references, profiling of respondents via structured questionnaires, and getting insights via detailed telephonic and face to face discussions.
The comprehensive approach ensured the collection and validation of information from a multitude of sources, contributing to the depth and reliability of the research findings.
Outcome
eQuantX’ research provided client the comprehensive insights into current and future treatment paradigms for COPD, empowered the client’s research and development team to identify unmet needs, explore innovative therapeutic approaches, and potentially contribute to the development of novel interventions, enhancing the competitiveness of their portfolio
Leveraging the unique panel management system, the research facilitated ongoing engagement with a panel comprising specialists treating respiratory diseases. The KOL insights enabled the client’s sales and marketing teams to build engagement strategies by better understanding physician preferences and opinions, which contributed to more effective communication and collaboration
Provided a detailed understanding of the competitive landscape to facilitate a smoother pathway for product development, regulatory approvals, and market launches
